Clinical Trial on a Food Supplement With Melatonin and Herbal Products to Improve Sleep Quality
NCT05459272 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2023-08-31
Summary
A randomized, double-blind, placebo-controlled clinical trial on the ability of a dietary supplement containing melatonin and herbal products to improve sleep quality in subjects with insomnia problems with a 15-day follow-up period.
Conditions
- Sleep Disorders
Interventions
- DIETARY_SUPPLEMENT
-
Aquilea Sueno Forte
The test product consists of a dietary supplement in the form of tablets with three layers containing: melatonin (1.95 mg/tablet) and herbal products (extracts from Griffonia, Passiflora, California poppy, Valerian, Melissa). Patients should take one tablet daily 30 min before go to bed during 7 days (from day 7 to day 14).
- OTHER
-
Placebo
The placebo will consist of tablets with three layers and with the same appearance as the dietary supplement under study, but containing no active ingredients. Patients should take one tablet daily 30 min before go to bed during 7 days (from day 7 to day 14).
Sponsors & Collaborators
-
Uriach Consumer Healthcare
lead INDUSTRY
Principal Investigators
-
Jesús Escribá, PhD · Principal Investigator
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-10
- Primary Completion
- 2023-09-30
- Completion
- 2023-10-30
Countries
- Spain
Study Locations
More Related Trials
-
Melatonin Treatment for Induced Transient Insomnia
NCT00950885 ·Status: COMPLETED ·Phase: NA
-
Melatonin and Nighttime Blood Pressure in African Americans--24 mg Study
NCT01114373 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Pharmacokinetic Study
NCT06801379 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effect of Melatonin on Cardiometabolic Risk- FULL
NCT02681887 ·Status: UNKNOWN ·Phase: PHASE3
-
The Relative Bio-availability of Oral and Oromucosal Melatonin in Different Formulations in Healthy Human Volunteers.
NCT02107079 ·Status: COMPLETED ·Phase: NA
-
Effects of Ramelteon (8mg) Alone and in Combination With Multi-Component Behavioral Therapy on Sleep and Circadian Phase in Patients With Chronic Insomnia
NCT01180855 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Assess Impact of Dietary Supplement on Sleep Health
NCT05971771 ·Status: UNKNOWN ·Phase: NA
-
Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.
NCT00414102 ·Status: COMPLETED ·Phase: PHASE4
-
Anxiolytic and Analgesic Effects of Melatonin
NCT02386319 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Dietary Supplementation With Melatonin in Targeting Sleep Quality
NCT06600633 ·Status: RECRUITING ·Phase: NA
-
Melatonin and the Metabolic Syndrome
NCT01038921 ·Status: COMPLETED ·Phase: PHASE2
-
Melatonin Supplementation for Delirium Prevention in Acutely Hospitalized Elderly
NCT00873379 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Melatonin on Sleep Quality in Patients Dementia
NCT03066518 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Commercial "Sleep Lotion" on Salivary Melatonin Levels and Sleep Quality in Undergraduates
NCT06053385 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy of Dietary Supplementation in Targeting Sleep Quality (NutriSom-01B)
NCT07200167 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Novel Inhaled Formulation of Melatonin to Treat Adults With Insomnia: Efficacy Study
NCT06802913 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Oral Melatonin in Critically Ill High-risk Patients
NCT00470821 ·Status: COMPLETED ·Phase: PHASE4
-
a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial
NCT06252571 ·Status: RECRUITING ·Phase: PHASE2
-
Melatonin and Nighttime Blood Pressure in African Americans-8 mg Study
NCT01114360 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Valerian on Insomnia in Menopausal Women
NCT05185219 ·Status: RECRUITING ·Phase: NA
-
Use of Endogenous Melatonin and 6-hydroxymelatonin as Biomarkers for CYP1A2
NCT04420611 ·Status: COMPLETED
-
Benefit of IQP-AO-101 for Sleep
NCT03114696 ·Status: COMPLETED ·Phase: NA
-
Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.
NCT00247390 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Study of TS-142 in Patients with Insomnia
NCT05453136 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance
NCT02156271 ·Status: COMPLETED ·Phase: PHASE4